Exploring the Role of At-home Semi-Quantitative Pregnancy Tests for Medical Abortion Follow-up

Summary

This study will examine the feasibility, acceptability and usability of a semi-quantitative urine pregnancy test (dBest One Step hCG Panel Test Kit) for at-home follow-up after early medical abortion using mifepristone+misoprostol. The study seeks to:

1. Assess the feasibility of using this test in lieu of standard one-week clinic-based follow up for determination of complete abortion status as part of normal service delivery. In Mexico, follow up will be in two weeks, as is standard care in that .
2. To determine if women using this test at home understand how to use it and can correctly interpret the results; is it practical.
3. Assess women's and provider's acceptability of using at-home pregnancy tests in lieu of clinic-based follow up for confirmation of complete medical abortion in the future.

Conditions

• Medical Abortion

Sponsors & Collaborators

• Stanford University

  collaborator OTHER

• Secretaría de Salud del Distrito Federal

  collaborator UNKNOWN

• Office National de la Famille et de la Population, Tunisia

  collaborator UNKNOWN

• Maternité de la Rabta, Tunisia

  collaborator UNKNOWN

• Clinique du Parc, Tunisia

  collaborator UNKNOWN

• Gynuity Health Projects

  lead OTHER

Principal Investigators

• Paul D Blumenthal, MD, MPH · Stanford University

• Beverly Winikoff, MD, MPH · Gynuity Health Projects

• Jennifer Blum, MPH · Gynuity Health Investigator

• Patricio Sanhueza Smith, MD · Secretaría de Salud del Distrito Federal

• Rym Fayala, MD · Office National de la Famille et de la Population

• Ezzedine Sfar · Maternité de la Rabta

• Hella Chelli · Clinique du Parc

• Rasha Dabash, MPH · Gynuity Health Projects

Eligibility

Min Age

18 Years

Max Age

55 Years

Sex

FEMALE

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2009-08-31

Primary Completion

2014-05-31

Countries

• United States
• Mexico
• Tunisia
• Vietnam

Study Locations